Mackenzie Financial
IMGN

Mackenzie Financial’s Immunogen Inc IMGN Stock Holding History

Mackenzie Financial’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,265
Closed -$423K – 1632
2023
Q4 		$423K Sell
14,265
-3,588
-20% -$71.5K ﹤0.01% 1046
2023
Q3 		$282K Hold
17,853
– – ﹤0.01% 1160
2023
Q2 		$336K Buy
17,853
+1,200
+7% +$14.2K ﹤0.01% 1139
2023
Q1 		$63.9K Sell
16,653
-89,250
-84% -$380K ﹤0.01% 1429
2022
Q4 		$525K Buy
105,903
+8,868
+9% +$48.1K ﹤0.01% 913
2022
Q3 		$464K Sell
97,035
-1,002
-1% -$5.28K ﹤0.01% 954
2022
Q2 		$441K Buy
98,037
+17,221
+21% +$74.8K ﹤0.01% 969
2022
Q1 		$385K Buy
80,816
+3,370
+4% +$18.7K ﹤0.01% 1044
2021
Q4 		$575K Buy
77,446
+8,916
+13% +$55.4K ﹤0.01% 978
2021
Q3 		$389K Buy
68,530
+4,734
+7% +$27.4K ﹤0.01% 1043
2021
Q2 		$420K Buy
+63,796
New +$445K ﹤0.01% 1014
2021
Q1 		– Sell
-81,110
Closed -$523K – 1215
2020
Q4 		$523K Buy
+81,110
New +$473K ﹤0.01% 830

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mackenzie Financial's IMGN Position: Q1 2024 in Review

Mackenzie Financial sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 14,265 shares — an estimated $423K sold.

Mackenzie Financial first reported a position in IMGN in Q4 2020 and held it in 12 quarters. The position peaked at $575K in Q4 2021. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Mackenzie Financial reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Mackenzie Financial sold 14,265 Immunogen Inc shares in Q1 2024, an estimated $423K.
  • Mackenzie Financial first reported a position in Immunogen Inc in Q4 2020 and held it in 12 quarters.
  • Mackenzie Financial's Immunogen Inc position peaked at $575K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Mackenzie Financial's 13F filing for Q1 2024, filed 10 May 2024.